BiolineRX Wins U.S. Patent for Heart Attack Drug

BiolineRX announced that it has obtained a U.S. patent for the composition of BL-1040, its novel medical device for prevention of cardiac remodeling following an acute myocardial infarction. The patent is good until August 2026.
Globes